200 related articles for article (PubMed ID: 10560360)
41. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
[TBL] [Abstract][Full Text] [Related]
42. Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients.
Ellis ME; Clink H; Ernst P; Halim MA; Padmos A; Spence D; Kalin M; Hussain Qadri SM; Burnie J; Greer W
Eur J Clin Microbiol Infect Dis; 1994 Jan; 13(1):3-11. PubMed ID: 8168557
[TBL] [Abstract][Full Text] [Related]
43. Antifungal prophylaxis with low doses fluconazole in patients with hematological malignancies.
Goranov S; Spasov E; Grudeva-Popova J; Vakrilov V
Folia Med (Plovdiv); 1999; 41(4):68-72. PubMed ID: 10786208
[TBL] [Abstract][Full Text] [Related]
44. Prophylactic use of fluconazole in neutropenic cancer patients.
Yamaç K; Senol E; Haznedar R
Postgrad Med J; 1995 May; 71(835):284-6. PubMed ID: 7596933
[TBL] [Abstract][Full Text] [Related]
45. Antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia.
Glasmacher A; Molitor E; Hahn C; Bomba K; Ewig S; Leutner C; Wardelmann E; Schmidt-Wolf IG; Mezger J; Marklein G; Sauerbruch T
Leukemia; 1998 Sep; 12(9):1338-43. PubMed ID: 9737680
[TBL] [Abstract][Full Text] [Related]
46. The use of itraconazole as prophylaxis against invasive fungal infection in blood and marrow transplant recipients.
Boyle BM; McCann SR
Transpl Infect Dis; 2000 Jun; 2(2):72-9. PubMed ID: 11429015
[TBL] [Abstract][Full Text] [Related]
47. Posaconazole prophylaxis in hematologic cancer.
Weiler S; Bellmann R
N Engl J Med; 2007 May; 356(21):2214; author reply 2215-8. PubMed ID: 17522407
[No Abstract] [Full Text] [Related]
48. Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.
Havlir DV; Dubé MP; McCutchan JA; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Kumar PN; White AC; Witt MD; Nightingale SD; Sepkowitz KA; MacGregor RR; Cheeseman SH; Torriani FJ; Zelasky MT; Sattler FR; Bozzette SA
Clin Infect Dis; 1998 Dec; 27(6):1369-75. PubMed ID: 9868644
[TBL] [Abstract][Full Text] [Related]
49. Management of fungal infection in neutropenic patients with fluconazole.
Brammer KW
Haematol Blood Transfus; 1990; 33():546-50. PubMed ID: 2182447
[TBL] [Abstract][Full Text] [Related]
50. Fluconazole versus oral polyenes in the prophylaxis of immunocompromised patients: a cost-minimization analysis.
Wakerly L; Craig AM; Malek M; Hoffmeyer U; Lloyd A; Valette F; Phillips R; Zabihollah M
J Hosp Infect; 1996 May; 33(1):35-48. PubMed ID: 8738200
[TBL] [Abstract][Full Text] [Related]
51. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study.
Laverdière M; Rotstein C; Bow EJ; Roberts RS; Ioannou S; Carr D; Moghaddam N
J Antimicrob Chemother; 2000 Dec; 46(6):1001-8. PubMed ID: 11102422
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.
Slavin MA; Osborne B; Adams R; Levenstein MJ; Schoch HG; Feldman AR; Meyers JD; Bowden RA
J Infect Dis; 1995 Jun; 171(6):1545-52. PubMed ID: 7769290
[TBL] [Abstract][Full Text] [Related]
53. Role of azoles in antifungal therapy.
Kauffman CA
Clin Infect Dis; 1996 May; 22 Suppl 2():S148-53. PubMed ID: 8722843
[TBL] [Abstract][Full Text] [Related]
54. Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia.
Glasmacher A; Hahn C; Molitor E; Sauerbruch T; Schmidt-Wolf IG; Marklein G
Mycoses; 1999; 42(5-6):395-402. PubMed ID: 10536431
[TBL] [Abstract][Full Text] [Related]
55. Prophylaxis of fungal infections with itraconazole during remission-induction therapy.
Prentice AG; Bradford GR
Mycoses; 1989; 32 Suppl 1():96-102. PubMed ID: 2561190
[TBL] [Abstract][Full Text] [Related]
56. Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia.
Gøtzsche PC; Johansen HK
BMJ; 1997 Apr; 314(7089):1238-44. PubMed ID: 9154027
[TBL] [Abstract][Full Text] [Related]
57. A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies. Multicentre Study Group.
Ninane J
Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):330-7. PubMed ID: 7794307
[TBL] [Abstract][Full Text] [Related]
58. Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis.
Barbaro G; Barbarini G; Calderon W; Grisorio B; Alcini P; Di Lorenzo G
Gastroenterology; 1996 Nov; 111(5):1169-77. PubMed ID: 8898629
[TBL] [Abstract][Full Text] [Related]
59. Prevention of fungal infections in hematology patients.
Philpott-Howard J
Infect Control Hosp Epidemiol; 1996 Aug; 17(8):545-51. PubMed ID: 8875301
[TBL] [Abstract][Full Text] [Related]
60. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group.
Young GA; Bosly A; Gibbs DL; Durrant S
Eur J Cancer; 1999 Aug; 35(8):1208-13. PubMed ID: 10615231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
